Rosemarie Mick

24.6k total citations · 1 hit paper
265 papers, 14.4k citations indexed

About

Rosemarie Mick is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Rosemarie Mick has authored 265 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Oncology, 61 papers in Pulmonary and Respiratory Medicine and 45 papers in Immunology. Recurrent topics in Rosemarie Mick's work include Immunotherapy and Immune Responses (35 papers), Cancer Immunotherapy and Biomarkers (25 papers) and Hematopoietic Stem Cell Transplantation (24 papers). Rosemarie Mick is often cited by papers focused on Immunotherapy and Immune Responses (35 papers), Cancer Immunotherapy and Biomarkers (25 papers) and Hematopoietic Stem Cell Transplantation (24 papers). Rosemarie Mick collaborates with scholars based in United States, Germany and Slovakia. Rosemarie Mick's co-authors include Robert H. Vonderheide, Everett E. Vokes, Mark J. Ratain, Brian J. Czerniecki, Carolyn E. Clark, MJ Ratain, Chelsea Combs, Sunil R. Hingorani, David A. Tuveson and Stephen M. Hahn and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Rosemarie Mick

262 papers receiving 14.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to Invasion

2007 745 citations Carolyn E. Clark, Sunil R. Hingorani et al. Cancer Research profile →

Peers

Countries citing papers authored by Rosemarie Mick

Since Specialization

Citations

This map shows the geographic impact of Rosemarie Mick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemarie Mick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemarie Mick more than expected).

Fields of papers citing papers by Rosemarie Mick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemarie Mick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemarie Mick. The network helps show where Rosemarie Mick may publish in the future.

Co-authorship network of co-authors of Rosemarie Mick

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemarie Mick. A scholar is included among the top collaborators of Rosemarie Mick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemarie Mick. Rosemarie Mick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exertional inspiratory capacity and operating lung volumes in health: a population-based study 2025 ·ERJ Open Research ·Beate Stubbe, Paulo de Tarso Müller, Anne Obst, (unknown), Rosemarie Mick, J. Alberto Neder, Ralf Ewert	0
2	FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma 2024 ·Clinical Cancer Research ·(unknown), (unknown), Alexander C. Huang, Xiaowei Xu, (unknown), (unknown), Rosemarie Mick, (unknown), Suzanne McGettigan, Kristin Kreider, Wei Xu, E. John Wherry, Lynn M. Schuchter, Ravi K. Amaravadi, Tara C. Mitchell, Michael D. Farwell	10
3	Integration of Radioembolization with CapTem for Liver-Dominant G2 NETs: Long-Term Outcomes 2023 ·Endocrine Abstracts ·Michael C. Soulen, (unknown), Rosemarie Mick, Jennifer R. Eads, Jeffrey I. Mondschein, Mandeep Dagli, (unknown), Nevena Damjanov, Charles L. Schneider, Keith A. Cengel, David C. Metz	1
4	A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes 2021 ·OncoImmunology ·Amit Maity, (unknown), Rosemarie Mick, Ramesh Rengan, Tara C. Mitchell, Ravi K. Amaravadi, Lynn M. Schuchter, Daniel A. Pryma, Dana Patsch, (unknown), (unknown), Andy J. Minn, Robert H. Vonderheide, John N. Lukens	18
5	Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in Botswana 2019 ·BMJ Open ·Surbhi Grover, Nicola M. Zetola, Doreen Ramogola‐Masire, Memory Bvochora‐Nsingo, (unknown), Rosemarie Mick, (unknown), (unknown), Hao Shen, Sebathu Chiyapo, (unknown), Nthabiseng Phaladze, Oathokwa Nkomazana, Harvey M. Friedman, John B. Jemmott, Bagele Chilisa, Erle S. Robertson	5
6	Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design Trial 2016 ·Clinical Cancer Research ·Lea Lowenfeld, Rosemarie Mick, Jashodeep Datta, Shuwen Xu, Elizabeth Fitzpatrick, Carla S. Fisher, Kevin R. Fox, Angela DeMichele, Paul J. Zhang, Susan P. Weinstein, Robert E. Roses, Brian J. Czerniecki	117
7	A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside 2013 ·Clinical Cancer Research ·Cheryl Lai-Lai Chiang, Lana E. Kandalaft, János L. Tanyi, Andrea R. Hagemann, Gregory T. Motz, Nikolaos Svoronos, Kathleen T. Montone, Gina Mantia-Smaldone, (unknown), Harvey Nisenbaum, Bruce L. Levine, Michael Kalos, Brian J. Czerniecki, Drew A. Torigian, Daniel J. Powell, Rosemarie Mick, George Coukos	181
8	A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer 2013 ·Journal of Translational Medicine ·Lana E. Kandalaft, Cheryl Lai-Lai Chiang, János L. Tanyi, Greg Motz, Klara Balint, Rosemarie Mick, George Coukos	53
9	HER‐2 pulsed dendritic cell vaccine can eliminate HER‐2 expression and impact ductal carcinoma in situ 2012 ·Cancer ·Anupama Sharma, Ursula Koldovsky, Shuwen Xu, Rosemarie Mick, Robert E. Roses, Elizabeth Fitzpatrick, Susan P. Weinstein, Harvey Nisenbaum, Bruce L. Levine, Kevin R. Fox, (unknown), Gary K. Koski, Brian J. Czerniecki	133
10	A Novel Dendritic Cell-based Immunization Approach for the Induction of Durable Th1-polarized Anti-HER-2/neu Responses in Women With Early Breast Cancer 2011 ·Journal of Immunotherapy ·Gary K. Koski, Ursula Koldovsky, Shuwen Xu, Rosemarie Mick, Anupama Sharma, Elizabeth Fitzpatrick, Susan P. Weinstein, Harvey Nisenbaum, Bruce L. Levine, Kevin R. Fox, Paul J. Zhang, Brian J. Czerniecki	95
11	Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to Invasion breakdown → 2007 ·Cancer Research ·Carolyn E. Clark, Sunil R. Hingorani, Rosemarie Mick, Chelsea Combs, David A. Tuveson, Robert H. Vonderheide	745
12	Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance 2007 ·Cancer Research ·Susan M. Domchek, Adri Recio, Rosemarie Mick, Carolyn E. Clark, Erica L. Carpenter, Kevin R. Fox, Angela DeMichele, Lynn M. Schuchter, Michael S. Leibowitz, (unknown), Barbara A. Vance, Gregory L. Beatty, Elizabeth Veloso, Michael D. Feldman, Robert H. Vonderheide	75
13	Immune Responses of Breast Cancer Patients to Mutated Epidermal Growth Factor Receptor (EGF-RvIII, ΔEGF-R, and de2–7 EGF-R) 2004 ·The Journal of Immunology ·Enkhtsetseg Purev, (unknown), Eric P. Miller, Rolf Swoboda, (unknown), Andres J. Klein–Szanto, Francesco M. Marincola, Rosemarie Mick, László Ötvös, William H. Wunner, Brigitte Birebent, Rajasekharan Somasundaram, Carol J. Wikstrand, Darell D. Bigner, Angela DeMichele, Géza Ács, Jesse A. Berlin, Dorothee Herlyn	26
14	Homocysteine and Prothrombin Fragment 1+2 Levels in Patients with Veno-Occlusive Disease after Stem Cell Transplantation 2003 ·Journal of Hematotherapy & Stem Cell Research ·John F. Gerecitano, Clarissa Mathias, Rosemarie Mick, Kathleen M. Duffy, Selina M. Luger, Edward A. Stadtmauer, Stephen J. Schuster, Donald E. Tsai, Sunita D. Nasta, Jesse A. Berlin, (unknown), Katherine A. High, David L. Porter	4
15	Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer 2002 ·Annals of Surgical Oncology ·Todd W. Bauer, Francis R. Spitz, Linda S. Callans, Abass Alavi, Rosemarie Mick, Susan P. Weinstein, Isabelle Bedrosian, Douglas L. Fraker, Thomas Bauer, Brian J. Czerniecki	75
16	Soluble Interleukin-2 Receptor Concentration As a Biochemical Indicator for Acute Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation 2000 ·Journal of Hematotherapy & Stem Cell Research ·Clarissa Mathias, Rosemarie Mick, Stephen Grupp, Kathleen M. Duffy, Frank Harris, Ginna G. Laport, Edward A. Stadtmauer, Selina M. Luger, (unknown), Mariusz A. Wasik, David Porter	26
17	Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer. 1996 ·Journal of Clinical Oncology ·Everett E. Vokes, Rosemarie Mick, M.S. Kies, M. Eileen Dolan, (unknown), Ilias Athanasiadis, D. Haraf, Mark Kozloff, Ralph R. Weichselbaum, Mark J. Ratain	48
18	Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986. 1994 ·PubMed ·(unknown), Rosemarie Mick, (unknown), HM Golomb	13
19	Source of Stem Cell Rescue: Bone Marrow versus Peripheral Blood Progenitors 1993 ·Journal of Hematotherapy ·Stephanie Williams, (unknown), (unknown), Rosemarie Mick	7
20	Cyclophosphamide and Thiotepa With Autologous Bone Marrow Transplantation in Patients With Solid Tumors 1988 ·JNCI Journal of the National Cancer Institute ·Joseph P. Eder, Karen H. Antman, Anthony Elias, Thomas C. Shea, Beverly A. Teicher, W. David Henner, S Schryber, Sylvia A. Holden, Robert W. Finberg, (unknown), Mary Flaherty, Rosemarie Mick, Lowell E. Schnipper, Emil Frei	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact